Adaptive Biotechnologies Corp Quarterly Debt-to-equity in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Adaptive Biotechnologies Corp quarterly Debt-to-equity history and growth rate from Q1 2020 to Q3 2024.
  • Adaptive Biotechnologies Corp Debt-to-equity for the quarter ending September 30, 2024 was 131 %, a 45.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 131 +41.1 +45.6% Sep 30, 2024
Q2 2024 118 +31.7 +36.9% Jun 30, 2024
Q1 2024 106 +29.8 +39.1% Mar 31, 2024
Q4 2023 97 +28.7 +42% Dec 31, 2023
Q3 2023 90.2 +29.7 +49.1% Sep 30, 2023
Q2 2023 86.1 +32.2 +59.8% Jun 30, 2023
Q1 2023 76.3 +24.1 +46.2% Mar 31, 2023
Q4 2022 68.3 +18 +35.6% Dec 31, 2022
Q3 2022 60.5 +10.7 +21.5% Sep 30, 2022
Q2 2022 53.9 +6.88 +14.6% Jun 30, 2022
Q1 2022 52.2 +2.97 +6.04% Mar 31, 2022
Q4 2021 50.4 -1.25 -2.42% Dec 31, 2021
Q3 2021 49.8 -4.18 -7.75% Sep 30, 2021
Q2 2021 47 -12 -20.4% Jun 30, 2021
Q1 2021 49.2 -43.5 -46.9% Mar 31, 2021
Q4 2020 51.6 Dec 31, 2020
Q3 2020 54 Sep 30, 2020
Q2 2020 59 Jun 30, 2020
Q1 2020 92.7 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.